anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

211,081-211,140 of 319,975

filter-aware
34
Amounts in USD million.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
35
Includes narrative explanation of Dansk Bank divestment and Dansk Supermarked Group classification.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
36
Contains two distinct financial notes (3 and 4) presented side-by-side.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
37
Contains two distinct financial tables and accompanying narrative disclosures for Maersk Group Q3 2015.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
38
Contains three distinct tables: development in number of shares, development in holding of own shares, and basis for calculating EPS.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
39
Standard accounting policy disclosure page for Maersk Group Q3 2015 interim report.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
40
Standard corporate colophon page listing board members, committees, auditors, and production credits.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
01
Slide 1
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
02
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
03
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
04
The slide outlines clinical trial progress (THIO-101, 102, 103), regulatory designations, and intellectual property status.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visualization to track drug development progress.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a three-column layout to present demographic and health statistics related to aging and cancer.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide illustrates the biological interaction between THIO (telomere targeting) and CPIs (checkpoint inhibitors) to induce tumor cell death.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Slide highlights a strategic partnership/validation event.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Why Now1 hit
12
The slide outlines a clinical trial process flow from initial NSCLC 2L+ patient entry through randomization to expansion.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses a bulleted list to present clinical trial safety findings.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
14
The slide highlights low-grade adverse events to support a claim of a favorable safety profile.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
15
The slide highlights exceptional progression-free survival in a high-need patient population.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
16
The slide defines DCR and provides a comparative analysis against standard of care (SOC) in third-line therapy.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
The chart uses a swimmer plot format to visualize patient status (on treatment vs follow-up) and survival duration.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
18
The chart shows tumor volume over time, highlighting the superior performance of the THIO + Atezo combination compared to monotherapies and control.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
19
The table compares clinical trial metrics for THIO-101 targets versus existing chemotherapy SoC.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
20
The slide shows a confocal microscopy image alongside a dot plot quantifying TIFs over time (0, 24, 48, 72 hours).MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
21
The slide outlines a clinical trial design using a basket/umbrella approach to test THIO in combination with various anti-PD-1/PD-L1 therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
22
The slide uses two line charts to demonstrate tumor volume reduction and the effect of rechallenge.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
23
The table compares clinical endpoints (Toxicity, ORR, PFS, OS) for the current standard of care (LONSURF) against the trial's goals.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
24
The slide shows tumor volume reduction over time in two different cancer models (SCLC and HCC) comparing control groups against various THIO-based combination treatments.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
25
The chart shows tumor volume over time (days) with error bars, highlighting the efficacy of THIO.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
26
Shows two distinct experiments: initial tumor growth inhibition and subsequent rechallenge immunity.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
27
The slide outlines a clinical development pathway involving immune activation and combination therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
28
The slide outlines both regulatory exclusivity (NCE status) and a multi-layered patent strategy.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
29
Includes a logo grid at the bottom representing past company affiliations.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
30
Includes footnotes regarding option ownership and cash proceeds, plus a note on insider ownership percentage.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
31
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
32
The chart compares the massive combined market of major CPIs ($42B) against a smaller reference point ($0.5B).MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
33
The slide highlights a recent acquisition event as a benchmark for valuation.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
34
The slide uses a timeline format with star icons to denote major inflection points.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
35
The slide serves as social proof and a milestone marker for the company's public listing.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
01
Slide 1
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
02
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
03
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
04
The slide presents a side-by-side comparison of income statement performance and a specific balance sheet snapshot.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Loop · Logic Chain1 hit
05
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
06
The chart compares quarterly container volumes between 2022 and 2023.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
07
The chart compares 2022 vs 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
08
The chart compares 2022 and 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
09
The chart shows a comparison of container volume by quarter for 2022 and 2023, with a specific callout for the 7.2% decline in Q2.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
10
The chart shows quarterly operating income for 2022 and 2023, with Q2 2023 highlighted as a range.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Satisfaction1 hit
01
Slide 1
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations 1 hit
02
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations 1 hit
03
The slide uses a structured list format to present key organizational strengths.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
The slide uses a three-column layout to categorize key performance indicators.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The diagram uses a three-circle Venn structure centered on the Moelis brand.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The map uses a dot-matrix style to represent continents, with circular callouts for regional office lists.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The diagram is a radial sunburst-style chart showing Moelis at the center, surrounded by primary sectors and their constituent sub-sectors.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a grid-based layout to categorize client deals by service line, with a sidebar for industry recognition.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit